The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00393159 |
Recruitment Status : Unknown
Verified October 2006 by Tel-Aviv Sourasky Medical Center.
Recruitment status was: Recruiting
First Posted : October 26, 2006
Last Update Posted : October 26, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Otitis Media Conductive Hearing Loss | Device: Ear Popper | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children |
Study Start Date : | October 2006 |

- Audiometry and tympanometry test results at at 7 weeks and 3 months from beginning of use of the ear popper.
- Otoscopic findings at at 7 weeks and 3 months from beginning of use of the ear popper.
- Hearing improvement at 7 weeks and 3 months from the beginning of the trial.
- Rate of referrals for tympanostomy tube insertion at 3 months

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 3 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Serous Otitis Media for More Then 3 months
- Conductive Hearing Loss of More Then 15 decibels.
- Tympanometry type B or C.
Exclusion Criteria:
- No History of Tympanostomy Tube Insertion or Adenoidectomy
- No Cranio or Facial Malformations
- No Acute Upper Respiratory Tract Infection or Acute Otitis Media

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00393159
Contact: Yael Oestreicher, MD | 972-3-6974517 | dkyo@barak-online.net.il | |
Contact: Ari DeRowe, MD | 972-3-6974517 |
Israel | |
ENT Unit, Dana Children's Hospital, Tel-Aviv Medical Center | Recruiting |
Tel-Aviv, Israel | |
Contact: Yael Oestreicher, MD 972-3-6974517 dkyo@barak-online.net.il | |
Principal Investigator: Yael Oestreicher, MD |
Principal Investigator: | Yael Oestreicher, MD | Tel Aviv Medical Center |
ClinicalTrials.gov Identifier: | NCT00393159 |
Other Study ID Numbers: |
TASMC06YO3567CTIL |
First Posted: | October 26, 2006 Key Record Dates |
Last Update Posted: | October 26, 2006 |
Last Verified: | October 2006 |
Effusion Otitis Media |
Ear Popper Children |
Hearing Loss Deafness Otitis Otitis Media Hearing Loss, Conductive Otitis Media with Effusion |
Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases Sensation Disorders Neurologic Manifestations Nervous System Diseases |